Literature DB >> 7216430

Selective antibacterial properties of lysozyme for oral microorganisms.

V J Iacono, B J MacKay, S DiRienzo, J J Pollock.   

Abstract

The antibacterial properties of lysozyme were investigated with oral microorganisms representing the seven serotypes (a through g) of Streptococcus mutans, Veillonella alcalescens, and the virulent (V) and avirulent (AV) strains of Actinomyces viscosus T14. Growth of bacteria in defined medium was monitored spectrophotometrically after the addition of various amounts (25 mug to 5 mg/ml) of enzyme. No growth inhibition of V. alcalescens was observed. Inhibition of A. viscosus T14(V) and A. viscosus T14(AV) occurred with 160 mug of lysozyme per ml. Of the S. mutans cultures tested, the serotype a and b strains were inhibited with as little as 25 mug of enzyme per ml, whereas e and f strains were most resistant to the bacteriostatic activity of lysozyme. The presence of dl-threonine or sucrose in growth medium did not significantly affect the results. A lysoplate assay was developed to rapidly survey the bacterial cultures for their susceptibility to the lytic ability of the enzyme. Lysis, as a measure of a zone of clearing in agarose plates, occurred for all microorganisms in the presence of lysozyme after the subsequent addition of NaCl or detergent. The bactericidal activity of lysozyme was determined on S. mutans BHT and S. mutans LM-7 by the pour plate technique. Preincubation of S. mutans LM-7 with as much as 1 mg of enzyme for 90 min did not affect viability or growth, whereas preincubation of S. mutans BHT with 1 mg of lysozyme resulted in no recoverable colony-forming units. An antigen containing extract of S. mutans LM-7 blocked the growth inhibitory property of lysozyme. Human lysozyme was a more effective antibacterial factor than hen egg white lysozyme. Total growth inhibition of S. mutans BHT was effected with 40 mug of human enzyme, and as little as 10 mug of human enzyme inhibited growth for greater than 20 h. The data presented indicate that different mechanisms may be responsible for the bacteriostatic, lytic, and bactericidal properties of the enzyme and that lysozyme is a selective but effective antibacterial factor for oral microorganisms.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7216430      PMCID: PMC551169          DOI: 10.1128/iai.29.2.623-632.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Cell wall metabolism of Bacillus subtilis [proceedings].

Authors:  W R de Boer; F J Kruyssen; J T Wouters
Journal:  Antonie Van Leeuwenhoek       Date:  1979       Impact factor: 2.271

2.  Physical studies of lysozyme. I. Characterization.

Authors:  A J SOPHIANOPOULOS; C K RHODES; D N HOLCOMB; K E VAN HOLDE
Journal:  J Biol Chem       Date:  1962-04       Impact factor: 5.157

3.  Electrophoretic mobility of oral streptococci.

Authors:  J Olsson; P O Glantz; B Krasse
Journal:  Arch Oral Biol       Date:  1976       Impact factor: 2.633

4.  Lysozyme insensitivity of bacteria indigenous to the oral cavity of man.

Authors:  R J Gibbons; J D de Stoppelaar; L Harden
Journal:  J Dent Res       Date:  1966 May-Jun       Impact factor: 6.116

5.  Chemical characterization, spatial distribution and function of a lipoprotein (murein-lipoprotein) of the E. coli cell wall. The specific effect of trypsin on the membrane structure.

Authors:  V Braun; K Rehn
Journal:  Eur J Biochem       Date:  1969-10

6.  Lysozyme: primary bactericidin in human plasma serum active against Bacillus subtilis.

Authors:  M E Selsted; R J Martinez
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

7.  Role of rabbit lysozyme in in vitro serum and plasma serum bactericidal reactions against Bacillus subtilis.

Authors:  S F Carroll; R J Martinez
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

8.  Chemical and immunological properties of the type f polysaccharide antigen of Streptococcus mutans.

Authors:  S Hamada; K Gill; H D Slade
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

9.  Purification and immunochemical characterization of type e polysaccharide antigen of Streptococcus mutans.

Authors:  S Hamada; H D Slade
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

10.  The effect of osmotic shock on the accessibility of the murein layer of exponentially growing Escherichia coli to lysozyme.

Authors:  B Witholt; M Boekhout
Journal:  Biochim Biophys Acta       Date:  1978-04-04
View more
  27 in total

1.  Killing of gram-negative bacteria by lactoferrin and lysozyme.

Authors:  R T Ellison; T J Giehl
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

2.  Production of bacteriolytic activity in the oral cavity by nutritionally variant streptococci.

Authors:  R Pompei; E Caredda; V Piras; C Serra; L Pintus
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

3.  Inhibition of bactericidal and bacteriolytic activities of poly-D-lysine and lysozyme by chitotriose and ferric iron.

Authors:  G R Tompkins; M M O'Neill; T G Cafarella; G R Germaine
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

4.  Arsenic alters transcriptional responses to Pseudomonas aeruginosa infection and decreases antimicrobial defense of human airway epithelial cells.

Authors:  Britton C Goodale; Erica J Rayack; Bruce A Stanton
Journal:  Toxicol Appl Pharmacol       Date:  2017-06-15       Impact factor: 4.219

5.  A comparison of bacterial aggregation induced by saliva, lysozyme, and zinc.

Authors:  E E Golub; J Cheruka; B Boosz; C Davis; D Malamud
Journal:  Infect Immun       Date:  1985-04       Impact factor: 3.441

6.  Lytic sensitivity of Actinobacillus actinomycetemcomitans Y4 to lysozyme.

Authors:  V J Iacono; P R Boldt; B J MacKay; M I Cho; J J Pollock
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

7.  Bacteriolysis of Veillonella alcalescens by lysozyme and inorganic anions present in saliva.

Authors:  M Tortosa; M I Cho; T J Wilkens; V J Iacono; J J Pollock
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

8.  Growth-inhibitory and bactericidal effects of human parotid salivary histidine-rich polypeptides on Streptococcus mutans.

Authors:  B J MacKay; L Denepitiya; V J Iacono; S B Krost; J J Pollock
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

9.  Glucose uptake by Streptococcus mutans, Streptococcus mitis, and Actinomyces viscosus in the presence of human saliva.

Authors:  G R Germaine; L M Tellefson
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

10.  Adherence of Streptococcus sanguis to hydroxyapatite coated with lysozyme and lysozyme-supplemented saliva.

Authors:  L M Tellefson; G R Germaine
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.